График акции NRx Pharmaceuticals, Inc.
О компании
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics that is in phase IIb/III clinical trials for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.EBITDA | 0 |
---|---|
Число акций ао | 0.00758 млрд |
P/E | 13.18 |
P/BV | 0.1825 |
EV/EBITDA | -1171.32 |
Цена ао | 0.516 |
ISIN | US6294441000 |
Сайт | https://www.nrxpharma.com |
Изменение цены за день: | +4.18% (2.39) |
---|---|
Изменение цены за неделю: | +15.81% (2.15) |
Изменение цены за месяц: | -17.82% (3.03) |
Изменение цены за 3 месяца: | -49.18% (4.9) |
Изменение цены за полгода: | +480.42% (0.429) |
Изменение цены за год: | +530.38% (0.395) |
Изменение цены с начала года: | +433.19% (0.467) |
Все параметры ⇨
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
Институционалы | Объем | Доля, % |
---|---|---|
Vanguard Group Inc | 144518 | 0.15 |
AdvisorShares Investments, LLC | 64263 | 0.07 |
Geode Capital Management, LLC | 41192 | 0.04 |
Blackrock Inc. | 29071 | 0.03 |
Renaissance Technologies, LLC | 20048 | 0.02 |
Royal Bank of Canada | 15021 | 0.02 |
One Wealth Management Investment & Advisory Services, LLC | 14040 | 0.01 |
Bridgeway Capital Management, Inc. | 12270 | 0.01 |
State Street Corporation | 11424 | 0.01 |
Northern Trust Corporation | 7500 | 0.01 |
ETF | Доля, % | Доходность за год, % | Дивиденды, % |
---|---|---|---|
AdvisorShares Psychedelics ETF | 4.01 | 0.20 | |
Руководитель | Должность | Оплата | Год рождения |
---|---|---|---|
Mr. Stephen H. Willard Esq. | Acting Corporate Secretary, CEO & Director | 500k | 1961 (63 года) |
Dr. Jonathan C. Javitt M.D., M.P.H. | Co-Founder, Chief Scientist Officer & Chairman | 630.2k | 1957 (67 лет) |
Dr. Riccardo Panicucci Ph.D. | Chief Manufacturing & Technology Officer | 240k | 1961 (63 года) |
Mr. Richard Clavano Narido | CFO & Treasurer | 255.01k | 1979 (45 лет) |
Suzanne Messere | Investor Relations | N/A | |
Dr. Philip T. Lavin Ph.D. | Chief Methodologist | N/A | 1947 (77 лет) |
Dr. Dennis K. McBride Ph.D. | Chief Strategy Officer & Senior Scientist | N/A | |
Mr. Matthew Patrick Duffy | Chief Business Officer | N/A | 1963 (61 год) |
Адрес: United States, Wilmington. DE, 1201 Orange Street - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.nrxpharma.com
Сайт: https://www.nrxpharma.com